Letter to the Editor
HACEK organisms exhibit low minimum inhibitory concentrations to ertapenem

https://doi.org/10.1016/j.jgar.2015.03.004Get rights and content

Section snippets

Funding

None.

Competing interests

CDB has received research support from bioMérieux and consulting fees from Thermo Fisher Scientific; MAP is the recipient of a bioMérieux Scholarship in Clinical Microbiology.

Ethical approval

None.

References (7)

  • K.C. Kugler et al.

    Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms

    Diagn Microbiol Infect Dis

    (1999)
  • J.E. Geraci et al.

    Symposium on infective endocarditis III. Endocarditis due to Gram-negative bacteria Report of 56 cases

    Mayo Clin Proc

    (1982)
  • L.M. Baddour et al.

    Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America

    Circulation

    (2005)
There are more references available in the full text version of this article.

Cited by (0)

1

Current address: Department of Laboratories, Cook Children's Medical Center, 801 Seventh Avenue, Fort Worth, TX 76104, USA.

View full text
Copyright © 2015 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.